Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 50

1.

Trunk alignment in different standing positions in healthy subjects and stroke patients -a comparative study with a simple method for the everyday practice.: Trunk alignment in healthy and stroke subjects.

Fehér-Kiss A, Nagy E, Domján A, Jakab K, Kránicz J, Horváth G.

Top Stroke Rehabil. 2018 Dec;25(8):561-568. doi: 10.1080/10749357.2018.1517490. Epub 2018 Oct 3.

PMID:
30281417
2.

ABCMdb reloaded: updates on mutations in ATP binding cassette proteins.

Tordai H, Jakab K, Gyimesi G, András K, Brózik A, Sarkadi B, Hegedus T.

Database (Oxford). 2017 Jan 1;2017(1). doi: 10.1093/database/bax023.

3.

Membrane Assays to Characterize Interaction of Drugs with ABCB1.

Fekete Z, Rajnai Z, Nagy T, Jakab KT, Kurunczi A, Gémes K, Herédi-Szabó K, Fülöp F, Tóth GK, Czerwinski M, Loewen G, Krajcsi P.

J Membr Biol. 2015 Dec;248(6):967-77. doi: 10.1007/s00232-015-9804-y. Epub 2015 Apr 30.

PMID:
25926125
4.

The first identified Central-Eastern European patient with genetically confirmed dentatorubral-pallidoluysian atrophy.

Zádori D, Tánczos T, Jakab K, Vécsei L, Klivényi P.

Ideggyogy Sz. 2015 Jan 30;68(1-2):68-71.

PMID:
25842919
5.

The role of cognitive training in the neurorehabilitation of a patient who survived a lightning strike. A case study.

Tánczos T, Zádori D, Jakab K, Hnyilicza Z, Klivényi P, Keresztes L, Engelhardt J, Németh D, Vécsei L.

NeuroRehabilitation. 2014;35(1):137-46. doi: 10.3233/NRE-141106.

PMID:
24990020
6.

Structure and function of BCRP, a broad specificity transporter of xenobiotics and endobiotics.

Jani M, Ambrus C, Magnan R, Jakab KT, Beéry E, Zolnerciks JK, Krajcsi P.

Arch Toxicol. 2014 Jun;88(6):1205-48. doi: 10.1007/s00204-014-1224-8. Epub 2014 Apr 29. Review.

PMID:
24777822
7.

A P-gp vesicular transport inhibition assay - optimization and validation for drug-drug interaction testing.

Herédi-Szabó K, Palm JE, Andersson TB, Pál Á, Méhn D, Fekete Z, Beéry E, Jakab KT, Jani M, Krajcsi P.

Eur J Pharm Sci. 2013 Jul 16;49(4):773-81. doi: 10.1016/j.ejps.2013.04.032. Epub 2013 May 15.

PMID:
23684934
8.

Prediction of Therapy Response and Prognosis in Leukemias by Flow Cytometric MDR Assays.

Kappelmayer J, Hevessy Z, Apjok A, Jakab KT.

EJIFCC. 2013 Jan 16;23(4):117-23. eCollection 2013 Jan.

9.

Synthesis and ABCG2 inhibitory activity of novel fumitremorgin C analogs--specificity and structure activity correlations.

Szolomajer-Csikós O, Beéry E, Kósa L, Rajnai Z, Jani M, Hetényi A, Jakab KT, Krajcsi P, Toth GK.

Med Chem. 2013 Jun 1;9(4):494-509.

PMID:
22931494
10.

Toward engineering functional organ modules by additive manufacturing.

Marga F, Jakab K, Khatiwala C, Shepherd B, Dorfman S, Hubbard B, Colbert S, Gabor F.

Biofabrication. 2012 Jun;4(2):022001. doi: 10.1088/1758-5082/4/2/022001. Epub 2012 Mar 12. Review.

PMID:
22406433
11.

Tissue engineering by self-assembly and bio-printing of living cells.

Jakab K, Norotte C, Marga F, Murphy K, Vunjak-Novakovic G, Forgacs G.

Biofabrication. 2010 Jun;2(2):022001. doi: 10.1088/1758-5082/2/2/022001. Epub 2010 Jun 2. Review.

12.

[The role of marginal donors in liver transplantation. The Hungarian experience].

Nemes B, Gelley F, Zádori G, Görög D, Fehérvári I, Jakab K, Fazakas J, Mándli T, Gerlei Z, Sárváry E, Doros A, Kóbori L.

Orv Hetil. 2009 Dec 6;150(49):2228-36. doi: 10.1556/OH.2009.28743. Hungarian.

PMID:
19939784
13.

Cadherin adhesion, tissue tension, and noncanonical Wnt signaling regulate fibronectin matrix organization.

Dzamba BJ, Jakab KR, Marsden M, Schwartz MA, DeSimone DW.

Dev Cell. 2009 Mar;16(3):421-32. doi: 10.1016/j.devcel.2009.01.008.

14.

Relating cell and tissue mechanics: implications and applications.

Jakab K, Damon B, Marga F, Doaga O, Mironov V, Kosztin I, Markwald R, Forgacs G.

Dev Dyn. 2008 Sep;237(9):2438-49. doi: 10.1002/dvdy.21684.

15.

[Biliary complications following orthotopic liver transplantation. The Hungarian experience].

Nemes B, Zádori G, Hartmann E, Németh A, Fehérvári I, Görög D, Máthé Z, Dávid A, Jakab K, Sárváry E, Piros L, Tóth S, Fazakas J, Gerlei Z, Járay J, Doros A.

Orv Hetil. 2008 May 25;149(21):963-73. doi: 10.1556/OH.2008.28363. Hungarian.

PMID:
18487111
16.

Tissue engineering by self-assembly of cells printed into topologically defined structures.

Jakab K, Norotte C, Damon B, Marga F, Neagu A, Besch-Williford CL, Kachurin A, Church KH, Park H, Mironov V, Markwald R, Vunjak-Novakovic G, Forgacs G.

Tissue Eng Part A. 2008 Mar;14(3):413-21. doi: 10.1089/tea.2007.0173.

PMID:
18333793
17.

Multiscale computational analysis of Xenopus laevis morphogenesis reveals key insights of systems-level behavior.

Robertson SH, Smith CK, Langhans AL, McLinden SE, Oberhardt MA, Jakab KR, Dzamba B, DeSimone DW, Papin JA, Peirce SM.

BMC Syst Biol. 2007 Oct 22;1:46.

18.

Three-dimensional tissue constructs built by bioprinting.

Jakab K, Damon B, Neagu A, Kachurin A, Forgacs G.

Biorheology. 2006;43(3,4):509-13.

PMID:
16912422
19.

The interplay of cell-cell and cell-matrix interactions in the invasive properties of brain tumors.

Hegedüs B, Marga F, Jakab K, Sharpe-Timms KL, Forgacs G.

Biophys J. 2006 Oct 1;91(7):2708-16. Epub 2006 Jul 7.

20.

Role of physical mechanisms in biological self-organization.

Neagu A, Jakab K, Jamison R, Forgacs G.

Phys Rev Lett. 2005 Oct 21;95(17):178104. Epub 2005 Oct 21.

PMID:
16383876
21.

Extensive flow cytometric characterization of plasmacytoid dendritic cell leukemia cells.

Gopcsa L, Banyai A, Jakab K, Kormos L, Tamaska J, Matolcsy A, Gogolak P, Rajnavolgyi E, Paloczi K.

Eur J Haematol. 2005 Oct;75(4):346-51.

PMID:
16146542
22.

Application of flow cytometry immunophenotyping and multidrug resistance assay in B-cell acute lymphoid leukemia and multiple myeloma.

Jakab K, Gopcsa L, Adam E, Domjan G, Sarkadi B, Paloczi K.

Neoplasma. 2005;52(1):36-42.

PMID:
15739024
23.

Organ printing: fiction or science.

Jakab K, Neagu A, Mironov V, Forgacs G.

Biorheology. 2004;41(3-4):371-5.

PMID:
15299269
24.

Engineering biological structures of prescribed shape using self-assembling multicellular systems.

Jakab K, Neagu A, Mironov V, Markwald RR, Forgacs G.

Proc Natl Acad Sci U S A. 2004 Mar 2;101(9):2864-9. Epub 2004 Feb 23.

25.

[Effect of imatinib treatment of gastrointestinal stromal tumors].

Eckhardt S, Pápai Z, Bodoky G, Horti J, Tamás K, Nagy T, Orosz Z, Sápi Z, Gödény M, Jakab K, Esik O, Trón L, Besznyák I.

Orv Hetil. 2003 Nov 9;144(45):2207-12. Hungarian.

PMID:
14686005
26.

Perceptual categorization is impaired in Huntington's disease: an electrophysiological study.

Antal A, Beniczky S, Kincses TZ, Jakab K, Benedek G, Vécsei L.

Dement Geriatr Cogn Disord. 2003;16(4):187-92.

PMID:
14512712
27.

Somatosensory evoked potentials correlate with genetics in Huntington's disease.

Beniczky S, Kéri S, Antal A, Jakab K, Nagy H, Benedek G, Janka Z, Vécsei L.

Neuroreport. 2002 Dec 3;13(17):2295-8.

PMID:
12488814
28.

"Pros and cons" on how to measure multidrug resistance in leukemias.

Kappelmayer J, Karászi E, Telek B, Jakab K.

Leuk Lymphoma. 2002 Apr;43(4):711-7. Review.

PMID:
12153155
29.

Diagnosis of soft tissue tumors by fine-needle aspiration with combined cytopathology and ancillary techniques.

Sápi Z, Antal I, Pápai Z, Szendröi M, Mayer A, Jakab K, Pajor L, Bodó M.

Diagn Cytopathol. 2002 Apr;26(4):232-42.

PMID:
11933269
30.

Alpha2-macroglobulin exon 24 (Val-1000-Ile) polymorphism is not associated with late-onset sporadic Alzheimer's dementia in the Hungarian population.

Janka Z, Juhász A, Rimanóczy A, Boda K, Márki-Zay J, Palotás M, Kuk I, Zöllei M, Jakab K, Kálmán J.

Psychiatr Genet. 2002 Mar;12(1):49-54.

PMID:
11901360
31.

[Role of molecular genetic investigations in the diagnosis of acute leukemias and in the detection of minimal residual disease].

Földi J, Páldi HP, Nahajevszky S, Jakab K, Regéczi N, Pálóczi K.

Orv Hetil. 2001 May 27;142(21):1097-102. Hungarian.

PMID:
11449838
32.

UVB irradiation-induced apoptosis increased in lymphocytes of Huntington's disease patients.

Jakab K, Novák Z, Engelhardt JI, Kemény L, Kálmán J, Vécsei L, Raskó I.

Neuroreport. 2001 Jun 13;12(8):1653-6.

PMID:
11409734
33.

Remarkably reduced transplant-related complications by dibromomannitol non-myeloablative conditioning before allogeneic bone marrow transplantation in chronic myeloid leukemia.

Barta A, Dénes R, Masszi T, Reményi P, Bátai A, Torbágyi E, Sipos A, Lengyel L, Jakab K, Gyódi E, Réti M, Földi J, Páldi-Haris P, Avalos M, Pálóczi K, Fekete S, Török J, Hoffer I, Jakab J, Váradi G, Kelemen E, Petrányi G.

Acta Haematol. 2001;105(2):64-70.

PMID:
11408706
34.

Calcein assay for multidrug resistance reliably predicts therapy response and survival rate in acute myeloid leukaemia.

Karászi E, Jakab K, Homolya L, Szakács G, Holló Z, Telek B, Kiss A, Rejtô L, Nahajevszky S, Sarkadi B, Kappelmayer J.

Br J Haematol. 2001 Feb;112(2):308-14.

PMID:
11167823
35.

[Immunophenotyping in acute leukemia: detection of minimal residual disease].

Pálóczi K, Nahajevszky S, Jakab K, Regéczy N, Gopcsa L, László E, Földi J.

Orv Hetil. 2000 Nov 12;141(46):2487-92. Hungarian.

PMID:
11126681
36.

Apolipoprotein E polymorphism in Pick's disease and in Huntington's disease.

Kálmán J, Juhász A, Majtényi K, Rimanóczy A, Jakab K, Gárdián G, Raskó I, Janka Z.

Neurobiol Aging. 2000 Jul-Aug;21(4):555-8.

PMID:
10924769
37.

Responses to single-dose thrombopoietin decrease with higher platelet counts in mice.

Kelemen E, Lehoczky D, Jakab K, Bátai A, Vargha P.

Acta Haematol. 1999 Mar;101(1):41-5.

PMID:
10085437
38.

Analysis of CAG repeat expansion in Huntington's disease gene (IT 15) in a Hungarian population.

Jakab K, Gárdián G, Endreffy E, Kalmár T, Bachrati C, Vécsei L, Raskó I.

Eur Neurol. 1999;41(2):107-10.

PMID:
10023115
39.

Diagnostics of multidrug resistance in cancer.

Szakács G, Jakab K, Antal F, Sarkadi B.

Pathol Oncol Res. 1998;4(4):251-7. Review.

40.

[A new radiation-free conditioning in bone marrow transplantation and dibromo-mannitol therapy in chronic myeloid leukemia].

Kelemen E, Dénes R, Barta A, Masszi T, Reményi P, Pálóczi K, Bátai A, Torbágyo E, Sipos A, Lengyel L, Jakab K, Gyódi E, Réti M, Földi J, Páldi-Haris P, Manuel A, Fekete S, Török J, Hoffer I, Jakab J, Váradi G, Petrányi G.

Orv Hetil. 1998 Aug 23;139(34):2003-1; discussion 2011-2. Review. Hungarian.

PMID:
9745304
41.

Parallel functional and immunological detection of human multidrug resistance proteins, P-glycoprotein and MRP1.

Holló Z, Homolya L, Hegedûs T, Müller M, Szakács G, Jakab K, Antal F, Sarkadi B.

Anticancer Res. 1998 Jul-Aug;18(4C):2981-7.

PMID:
9713496
42.

Lymphocyte subset reconstitution after allogeneic bone marrow transplantation using radiation-free conditioning regimen for patients with chronic granulocytic leukemia.

Milosevits J, Dénes R, Poros A, Reményi P, Bátai A, Barta A, Masszi T, Lengyel L, Jakab K, Földi J, et al.

Int J Hematol. 1995 Jul;62(1):27-33.

PMID:
7670005
43.

[Survey of one hundred patients with chronic granulocytic leukemia from the view of recent developments].

Jakab K, Triska E, Kelemen E.

Orv Hetil. 1995 Jan 22;136(4):171-5. Hungarian.

PMID:
7532845
45.

[Amphotericin B resistant severe hepato-splenic candidiasis, responding to fluconazole, in a patient following bone marrow transplantation].

Jakab K, Kelemen E, Váradi G, Török I.

Orv Hetil. 1991 Mar 24;132(12):643-5. Hungarian.

PMID:
2011389
46.

Immune-mediated models of motor neuron destruction in the guinea pig.

Engelhardt JI, Appel SH, Jakab K, García J, Stefani E.

Adv Neurol. 1991;56:369-79. No abstract available.

PMID:
1853769
47.

Amphotericin-resistant invasive hepatosplenic candidiasis controlled by fluconazole.

Jakab K, Kelemen E, Prinz G, Török I.

Lancet. 1990 Feb 24;335(8687):473-4. No abstract available.

PMID:
1968194
48.

[A case of Wegener's granulomatosis diagnosed during life].

Koncz J, Jakab K.

Fogorv Sz. 1976 Jul;69(7):203-6. Hungarian. No abstract available.

PMID:
1065591
49.

An assay for selecting high risk population for gastric cancer by studying environmental factors.

Málnási G, Jakab S, Incze A, Apostol A, Csapó JM, Szabó E, Csapó JJ, Jakab K.

Neoplasma. 1976;23(3):333-41.

PMID:
958535
50.

[Malignant ovarian tumors causing uterine uterine bleeding].

Tamás Z, Tuka P, Jakab K.

Orv Hetil. 1971 Jan 17;112(3):151-2. Hungarian. No abstract available.

PMID:
5547501

Supplemental Content

Support Center